Epidemiology and clinical outcomes of light-chain amyloidosis in Sweden: A nationwide population-based study.

Autor: Mellqvist UH; Section of Hematology and Coagulation, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden., Cai Q; Janssen Global Services, Titusville, New Jersey, USA., Hester LL; Janssen Research & Development, Horsham, Pennsylvania, USA., Grövdal M; Janssen-Cilag, Solna, Sweden., Börsum J; SDS Life Science, Stockholm, Sweden., Rahman I; SDS Life Science, Stockholm, Sweden., Ammann EM; Janssen Global Services, Raritan, New Jersey, USA., Hansson M; Department of Hematology, Sahlgrenska Academy, Göteborg University and Sahlgrenska University Hospital, Gothenburg, Sweden.; Department of Hematology, Skåne University Hospital, Lund, Sweden.

Publikováno v: European journal of haematology [Eur J Haematol] 2023 Nov; Vol. 111 (5), pp. 697-705. Date of Electronic Publication: 2023 Aug 02.

Update on prevalence of diagnosed systemic lupus erythematosus (SLE) by major health insurance types in the US in 2016.

Autor: Wang Y; Janssen Research & Development, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA., Hester LL; Janssen Research & Development, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA. LHester@ITS.JNJ.com., Lofland J; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Rose S; Janssen Research & Development, LLC, Spring House, PA, USA., Karyekar CS; Janssen Scientific Affairs, LLC, Horsham, PA, USA., Kern DM; Janssen Research & Development, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA., Blacketer M; Janssen Research & Development, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA., Davis K; Janssen Research & Development, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA., Shields-Tuttle K; Janssen Research & Development, LLC, Spring House, PA, USA.

Publikováno v: BMC research notes [BMC Res Notes] 2022 Jan 09; Vol. 15 (1), pp. 5. Date of Electronic Publication: 2022 Jan 09.

Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.

Autor: Hester LL; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Janssen Research & Development, LLC, Titusville, New Jersey., Park SI; Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.; Division of Hematology and Oncology, Levine Cancer Institute, Charlotte, North Carolina., Wood WA; Leukemia, Lymphoma, and Myeloma Program, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Stürmer T; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Brookhart MA; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Lund JL; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

Publikováno v: Cancer [Cancer] 2019 Apr 01; Vol. 125 (7), pp. 1101-1112. Date of Electronic Publication: 2018 Dec 11.

Reply to: comparative effectiveness medicines research cannot assess efficacy.

Autor: Hester LL; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, 135 Dauer Drive, 2101 McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC 1-609-703-6927, USA. Electronic address: llhester@live.unc.edu., Poole C; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, 135 Dauer Drive, 2101 McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC 1-609-703-6927, USA., Suarez EA; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, 135 Dauer Drive, 2101 McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC 1-609-703-6927, USA., Der JS; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, 135 Dauer Drive, 2101 McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC 1-609-703-6927, USA., Anderson OG; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, 135 Dauer Drive, 2101 McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC 1-609-703-6927, USA., Almon KG; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, 135 Dauer Drive, 2101 McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC 1-609-703-6927, USA., Shirke AV; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, 135 Dauer Drive, 2101 McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC 1-609-703-6927, USA., Brookhart MA; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina-Chapel Hill, 135 Dauer Drive, 2101 McGavran-Greenberg Hall, CB #7435, Chapel Hill, NC 1-609-703-6927, USA.

Publikováno v: Journal of clinical epidemiology [J Clin Epidemiol] 2017 Dec; Vol. 92, pp. 130-132. Date of Electronic Publication: 2017 Sep 12.

Methodologic Issues When Estimating Risks in Pharmacoepidemiology.

Autor: Edwards JK; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Hester LL; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Gokhale M; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Epidemiology, Real World Evidence, GlaxoSmithKline, Collegeville, PA, USA., Lesko CR; Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA.

Publikováno v: Current epidemiology reports [Curr Epidemiol Rep] 2016 Dec; Vol. 3 (4), pp. 285-296. Date of Electronic Publication: 2016 Sep 13.